Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Pfizer 90 day period expired

<< Previous

Bullboard Posts

Next >>

Comment by Quentin30on Mar 03, 2023 9:39am

188 Views

Post# 35317189

RE:RE:Pfizer 90 day period expired

They did have a deal 4-5 years ago... they're called Adlai Nortye. And that doesn't appear to be going anywhere.

so if the 90 days is over, what is the mostly likely..

Pfizer is interested in making a deal
Pfizer is NOT interested in making a deal.
Pfizer will wait until Bracelet-1 data is published.

We still have another few months to wait for this data to mature... after 20+ years that's not such a drag. But Matt still states if the results are good...having changed the presentation slides recently, it sounds like he's not overly positive... just my take on it.

<< Previous

Bullboard Posts

Next >>

This junior mining stock offers billions in market exposure